查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1860485

抗菌成分市场：全球预测（2025-2032 年），按应用、类型、剂型、功能和来源划分

Antimicrobial Ingredients Market by Application, Type, Form, Function, Source - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，抗菌成分市场将成长至 81.1 亿美元，复合年增长率为 7.06%。

关键市场统计数据
基准年 2024 47亿美元
预计年份：2025年 50.4亿美元
预测年份 2032 81.1亿美元
复合年增长率 (%) 7.06%

简要介绍不断发展的抗菌成分领域以及产品开发人员和采购经理需要考虑的策略因素

由于监管要求的变化、消费者偏好的转变以及活性成分和递送系统技术的进步，抗菌成分领域正在迅速发展。本执行摘要概述了与产品开发人员、配方师、采购团队和法规事务负责人最相关的趋势。它揭示了新兴的天然替代品、改进的合成化学方法和创新配方如何重塑从医疗和个人护理到农业和水处理等应用领域。

技术进步的融合、法规结构的收紧以及终端用户需求的改变，正在重塑竞争与创新的格局。

抗菌成分产业正经历技术、法规和需求的变革，从而改变竞争和创新的格局。天然萃取物纯化技术的进步、用于标靶作用的改良有机酸以及新型银基递送系统的出现，使配方师能够在降低毒性风险的同时，获得更广谱的抗菌频谱。同时，包封技术、缓释性粉末和凝胶流变学的改进，也为涂层和医疗设备介面提供持续保护提供了更多可能性。

检验了近期美国关税如何重塑采购决策、供应商策略和供应链弹性规划。

美国近期采取的关税措施及相关贸易政策调整，为全球抗菌成分供应链和筹资策略带来了新的复杂性。对某些类别的化学中间体和成品活性成分提高进口关税，导致到岸成本上升，促使买家重新评估其筹资策略。同时，为了降低单一国家风险，企业更加重视近岸外包和多源采购。这些商业性应对措施导致供应商合约重新评估、前置作业时间缓衝期延长，并在某些情况下加快了国内生产投资。

透过对应用、化学成分、製剂形式、功能和原材料来源进行全面的細項分析，指导配方和供应链策略。

细分市场分析揭示了不同应用、成分类型、製剂形式、功能和成分来源所带来的独特需求模式和技术要求，这些因素共同定义了策略性产品路径。在农业领域，饲料添加剂优先考虑肠道耐受性，而作物保护活性成分则需要环境持久性和对非目标物种的安全性，二者的需求截然不同。在食品饮料领域，食品保藏化学品优先考虑保质期，而表面消毒剂则必须保持与食品接触的兼容性，二者的需求也截然不同。在医疗保健领域，医院消毒剂需要高效性，而医疗设备被覆剂则需要生物相容性黏附性和缓释性，二者的需求也截然不同。在家用清洁剂领域，洗衣添加剂注重织物安全性，而表面清洁剂则力求达到零残留性能，二者的需求也截然不同。个人护理应用涵盖抗菌皂、除臭剂和口腔清洁用品等，每种产品都有其独特的感官和监管限制。水处理需求因饮用水应用（需要微量安全）和污水处理应用（优先考虑对微生物负荷的广泛抵抗力）而异。

区域趋势和策略要务正在影响全球的监管合规、供应链设计和商业化路径。

区域趋势正在影响全球抗菌成分市场的需求结构、监管重点和创新生态系统。在美洲，强劲的医疗保健机构需求和成熟的消费市场（追求永续性认证和监管透明度）是推动商业活动的主要动力。在此环境下，供应商重视检验的安全资料和可扩展的生产方法，而买家则寻求拥有完善的品管系统和本地化生产的供应商，以降低物流风险。

抗菌成分领域主要企业的关键属性和策略倡议：从配方创新到供应链韧性和卓越的监管能力。

在抗菌成分领域，产业领先地位越来越依赖技术差异化、监管专业知识和灵活生产能力的结合。主要企业正在投资先进的配方平台，提升天然萃取物标准化能力，并扩大包封和缓释技术的规模，以实现持久的抗菌性能。这些投资通常辅以与契约製造和专业配方商的策略联盟，以弥补产能缺口，并加速新型活性成分的市场化进程。

为领导者提供实用建议，帮助他们协调创新、监管准备和供应链策略，以加速商业化并增强韧性。

行业领导者应采取多管齐下的方法，将研发重点与监管前瞻性和商业性灵活性相结合，以抓住新的机会。首先，优先发展兼顾疗效、安全性和环境效益的化学和递送系统，将降低下游配方调整的风险，并有助于产品获得更广泛的市场认可。其次，投资供应商多元化和近岸外包，能够更快地回应关键应用，同时降低受政策主导的贸易中断影响的风险。第三，建立强大的监管情报能力并儘早与监管机构沟通，可以缩短核准週期，避免合规障碍。

调查方法：结合一手访谈、技术文献综合与供应链分析，以确保基于实务者观点的严谨见解。

本研究采用多层次调查方法进行综合分析，结合一手访谈、技术文献综述及跨产业趋势分析，以全面了解抗菌成分的发展趋势。一手资料透过对製剂科学家、采购主管、法规事务专业人员和生产负责人进行结构化访谈收集，旨在深入了解研发重点、采购限制和合规实践等方面的实际问题。这些定性资料与权威技术出版物、安全性评估和监管检验进行三角验证，以确保事实准确性和技术深度。

总结报告整合了技术、监管和供应链等主题，概述了实现持续竞争优势的策略要务。

摘要，抗菌成分产业正处于转折点，技术创新、不断变化的法规以及地缘政治因素共同塑造产品开发和筹资策略。优先考虑安全和永续化学技术、实现供应链多元化并加强跨职能团队协作的企业，将更有能力满足不断变化的终端用户需求。对包封技术、缓释性和标准化天然萃取物生产的策略性投资将有助于企业获得竞争优势，而与监管机构的密切合作则能缩短关键应用领域的合规时间。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 化妆品配方中对用于对抗皮肤病原体的多功能抗菌肽的需求不断增长
  • 将银奈米颗粒整合到先进的伤口敷料中，以实现持续的抗菌功效
  • 在食品包装中利用天然植物来源的抗菌剂取代合成防腐剂
  • 开发用于高接触医疗设备和设备的抗生物膜抗菌涂层
  • 新的监管趋势推动了非三唑类抗真菌药物在家庭清洁产品中的应用
  • 创新酵素基抗菌解决方案，对抗农业中的抗生素抗药性

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 抗菌成分市场：依应用领域划分

  • 农业
    • 饲料添加剂
    • 作物保护
  • 食品/饮料
    • 食品保藏
    • 表面卫生管理
  • 卫生保健
    • 医院消毒剂
    • 医疗设备涂层
  • 家用清洁剂
    • 洗衣添加物
    • 表面清洁剂
  • 个人护理
    • 抗菌皂
    • 除臭剂
    • 口腔清洁用品
  • 水处理
    • 饮用水
    • 污水处理

第九章 抗菌成分市场：依类型划分

  • 天然萃取物
    • 精油
      • 茶树油
      • 百里香油
    • 植物萃取物
      • 葡萄柚籽萃取物
  • 有机酸
    • 苯甲酸
    • 丙酸
    • 山梨酸
  • 酚类化合物
    • 邻苯基苯酚
    • 三氯生
  • 季铵化合物
    • 苯扎氯铵
    • 二癸基二甲基氯化铵
  • 银型
    • 胶体银
    • 银色沸石

第十章 抗菌成分市场：依剂型划分

  • 形式
    • 气雾泡沫
    • 非气雾剂泡沫
  • 凝胶
    • 标准凝胶
    • 触变凝胶
  • 液体
    • 水溶液
    • 乳液
  • 粉末
    • 颗粒
    • 微胶囊

第十一章 抗菌成分市场：依功能划分

  • 涂层
    • 工业涂料
    • 医疗设备涂层
  • 消毒剂
    • 器械消毒剂
    • 表面消毒剂
  • 防腐剂
    • 化妆品防腐剂
    • 食品防腐剂
  • 消毒剂
    • 干洗手剂
    • 表面消毒剂

第十二章 抗菌成分市场：依原料划分

  • 自然的
    • 微生物发酵
      • 细菌素
      • 酵素萃取物
    • 植物来源
  • 合成
    • 生物基合成
    • 石油化工衍生性商品

第十三章：各地区抗菌成分市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 抗菌成分市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国抗菌成分市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Lonza Group AG
    • BASF SE
    • Dow Inc.
    • Evonik Industries AG
    • Solvay SA
    • DuPont de Nemours, Inc.
    • LANXESS AG
    • Clariant AG
    • Arkema SA
    • Ashland Global Holdings Inc.
Product Code: MRR-69324464D0CE

The Antimicrobial Ingredients Market is projected to grow by USD 8.11 billion at a CAGR of 7.06% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.70 billion
Estimated Year [2025] USD 5.04 billion
Forecast Year [2032] USD 8.11 billion
CAGR (%) 7.06%

Concise introduction framing the evolving antimicrobial ingredients landscape and the strategic considerations for product developers and procurement leaders

The antimicrobial ingredients landscape is undergoing rapid evolution driven by shifting regulatory expectations, changing consumer preferences, and technological advances in active chemistries and delivery systems. This executive summary synthesizes the most pertinent developments affecting product developers, formulators, procurement teams, and regulatory affairs professionals. It highlights how emerging natural alternatives, refined synthetic chemistries, and novel formulation formats are reshaping applications from healthcare and personal care to agriculture and water treatment.

In this context, stakeholders must navigate an increasingly complex intersection of functionality, safety, and sustainability. Across sectors, there is growing emphasis on compatibility with sensitive substrates, non-toxic residue profiles, and lifecycle considerations that influence procurement and development decisions. To facilitate decision-making, this analysis distills strategic inflections, regulatory headwinds, and actionable segmentation insights that equip leaders to prioritize investments, adapt formulations, and strengthen supply chain resilience. The goal is to provide a clear, concise briefing that frames opportunities and responses without prescriptive numeric projections, so organizations can apply findings directly to their operational and strategic imperatives.

How converging technological advances, stricter regulatory frameworks, and changing end-use demands are reshaping competitive dynamics and innovation pathways

The antimicrobial ingredients sector is seeing transformative shifts across technology, regulation, and demand that are altering competitive dynamics and innovation pathways. Advances in natural extract purification, the refinement of organic acids for targeted efficacy, and new silver-based delivery systems are enabling formulators to achieve broader antimicrobial spectra while reducing toxicological concerns. At the same time, improvements in encapsulation, controlled-release powders, and gel rheology are expanding functional possibilities for long-lasting protection in coatings and medical device interfaces.

Regulatory landscapes are tightening in many jurisdictions, prompting manufacturers to reassess legacy actives and accelerate reformulation programs. Moreover, cross-sector convergence is intensifying; innovations developed for healthcare applications are migrating into personal care and household cleaners, and agricultural uses are borrowing preservation technologies from food safety science. As a result, strategic partnerships between ingredient suppliers, contract manufacturers, and application specialists are becoming more prevalent to bridge technical expertise and speed-to-market. Collectively, these shifts are creating both disruption and opportunity, and organizations that align R&D, regulatory foresight, and commercial strategy will be best positioned to capitalize on the next wave of demand.

Examination of how recent tariff measures in the United States have reshaped sourcing decisions, supplier strategies, and supply chain resilience planning

Recent tariff actions and associated trade policy shifts in the United States have introduced new layers of complexity for global supply chains and procurement strategies in antimicrobial ingredients. Increased import duties on certain classes of chemical intermediates and finished actives have raised landed costs and prompted buyers to revisit sourcing strategies, with a parallel focus on nearshoring and multi-sourcing to mitigate exposure to single-country risks. These commercial responses have led to a re-evaluation of supplier contracts, longer lead-time buffers, and in some instances the acceleration of domestic manufacturing investments.

Beyond direct cost effects, tariffs have influenced supplier behavior: some manufacturers are absorbing margin impacts to retain market access while others are redirecting exports to more favorable markets. The policy environment has also catalyzed an uptick in qualification of alternate chemistries and locally produced natural extracts that reduce reliance on tariff-affected imports. For companies integrating antimicrobial ingredients into critical applications, these dynamics emphasize the need for more robust scenario planning, expanded supplier audits, and contractual flexibility to manage price volatility and compliance obligations. In short, the tariff landscape is a strategic factor that now informs sourcing, innovation prioritization, and capital allocation decisions across the value chain.

Comprehensive segmentation insights across applications, chemistries, formulation formats, functional roles, and source origins to guide formulation and supply chain strategies

Segmentation analysis reveals nuanced demand patterns and technical requirements across applications, ingredient types, formulation forms, functional roles, and source origins that together define strategic product pathways. In agriculture, need profiles diverge between animal feed additives that prioritize gut-targeted tolerability and crop protection actives that demand environmental persistence and safety for non-target species; the food and beverage domain separates food preservation chemistries focused on shelf life from surface sanitation agents that must maintain food-contact compatibility. Healthcare applications bifurcate between hospital disinfectants with high-level efficacy requirements and medical device coatings that require biocompatible adhesion and controlled release. Household cleaners differentiate laundry additive formulations optimized for fabric safety and surface cleaners engineered for residue-free performance. Personal care applications cover a spectrum from antimicrobial soaps to deodorants and oral care products, each with unique sensory and regulatory constraints. Water treatment needs split between drinking water applications requiring trace-level safety and wastewater treatment where broader robustness against microbial loads is prioritized.

When viewed by type, natural extracts such as essential oils and plant extracts are being engineered for consistent potency, with subtypes like tea tree oil, thyme oil, and grapefruit seed extract increasingly standardized. Organic acids such as benzoic, propionic, and sorbic acids offer preservative function with established safety profiles, while phenolic compounds like orthophenylphenol present strong surface activity but face regulatory scrutiny in some jurisdictions. Quaternary ammonium compounds remain foundational for many disinfectant applications, with benzalkonium chloride and didecyldimethylammonium chloride as prevalent subtypes, and silver-based actives including colloidal silver and silver zeolite are advancing in coatings and medical device technologies.

Form-driven differentiation matters: foam formats-both aerosol and non-aerosol-provide user-friendly delivery for hand and surface products; gel systems, whether standard or thixotropic, support controlled application; liquid forms such as aqueous solutions and emulsions underpin many disinfectants and preservatives; powders in granules or microcapsules enable long-term storage stability and targeted release. Functional segmentation clarifies end-use design: coatings, whether industrial or for medical devices, demand durability and compatibility; disinfectants require instrument-level and surface efficacy; preservatives must balance cosmetic and food safety constraints; and sanitizers emphasize rapid, broad-spectrum activity suitable for hands or surfaces. Finally, source considerations-natural versus synthetic-drive procurement and branding decisions, with microbial fermentation derivatives like bacteriocins and enzymatic extracts competing with bio-based synthetics and petrochemical-derived actives on cost, sustainability, and regulatory acceptance. Together, these layered segmentation perspectives inform formulation trade-offs, supply chain sourcing, and regulatory strategies that companies must reconcile when prioritizing product pipelines and commercialization pathways.

Region-specific dynamics and strategic imperatives that influence regulatory compliance, supply chain design, and commercialization pathways across global geographies

Regional dynamics are shaping demand composition, regulatory priorities, and innovation ecosystems across the global antimicrobial ingredients landscape. In the Americas, commercial activity is driven by strong institutional demand from healthcare and a mature consumer market that expects sustainability credentials and regulatory transparency. This environment encourages suppliers to emphasize validated safety data and scalable manufacturing practices, while buyers seek suppliers with robust quality systems and domestic or nearshore production to reduce logistical risk.

In Europe, the Middle East and Africa region, regulatory rigor and public procurement standards drive adoption cycles, with an emphasis on harmonized safety assessments and restrictions on certain legacy chemistries. This regulatory posture, coupled with accelerating interest in bio-based and low-toxicity alternatives, is fueling partnerships between ingredient innovators and local formulators. In the Asia-Pacific region, high-volume manufacturing capacity, diverse application demand across agriculture, personal care, and water treatment, and variable regulatory regimes create both fast adoption pathways and complex compliance requirements. As a result, companies operating across regions must tailor formulation profiles, regulatory strategies, and commercial approaches to align with local certification expectations, distribution models, and end-user preferences. Coordinated regional strategies that balance central R&D with localized compliance and marketing will be essential for scaling successful product introductions.

Key attributes and strategic moves that distinguish leading companies in antimicrobial ingredients, from formulation innovation to supply chain resilience and regulatory excellence

Industry leadership in antimicrobial ingredients increasingly rests on the ability to combine technical differentiation, regulatory expertise, and agile manufacturing. Leading companies are investing in advanced formulation platforms, expanding capabilities in natural extract standardization, and scaling encapsulation and controlled-release technologies to deliver sustained antimicrobial performance. These investments are often complemented by strategic collaborations with contract manufacturers and specialty formulators to bridge capability gaps and accelerate market entry for novel actives.

High-performing players also prioritize transparent safety dossiers and third-party validation to ease regulatory review and gain buyer confidence, particularly for healthcare and food-contact applications. Operational excellence in supply chain management-such as diversification of raw material sources and qualification of backup suppliers-has become a competitive advantage, reducing the operational impact of trade disruptions. Furthermore, top-tier companies are leveraging sustainability metrics and life-cycle assessments to support product claims and satisfy increasingly scrutinizing procurement teams. Collectively, these capabilities define a profile of companies that can sustain innovation cycles, maintain compliance across multiple jurisdictions, and respond rapidly to shifts in end-user demands.

Actionable recommendations for leaders to align innovation, regulatory preparedness, and supply chain strategies to accelerate commercialization and build resilience

Industry leaders should adopt a multifaceted approach that aligns R&D priorities with regulatory foresight and commercial agility to capture emerging opportunities. First, prioritizing chemistries and delivery systems that balance efficacy with demonstrable safety and environmental credentials will reduce downstream reformulation risk and support broader market acceptance. Second, investing in supplier diversification and nearshoring options will mitigate exposure to policy-driven trade disruptions while enabling faster response times for critical applications. Third, building robust regulatory intelligence capabilities and engaging early with authorities can shorten approval cycles and preempt compliance obstacles.

In parallel, companies should pursue strategic partnerships with contract manufacturers and application specialists to accelerate scale-up and commercialization. Cross-functional collaboration between formulation scientists, regulatory affairs, and commercial teams will ensure that product profiles meet end-user constraints and procurement expectations. Finally, embedding sustainability metrics and transparent performance validation into product communications will strengthen brand trust and open procurement pathways with institutional buyers. These actions, taken together, create a pragmatic roadmap for enhancing resilience, accelerating time-to-market, and future-proofing product portfolios against evolving regulatory and customer demands.

Methodology overview explaining how primary interviews, technical literature synthesis, and supply chain analysis were integrated to ensure rigorous, practitioner-informed findings

This research synthesis draws on a layered methodology that integrates primary interviews, technical literature review, and cross-sector trend analysis to produce a holistic view of antimicrobial ingredient dynamics. Primary inputs were collected through structured interviews with formulation scientists, procurement executives, regulatory affairs specialists, and manufacturing leaders to capture practical insights into development priorities, sourcing constraints, and compliance practices. These qualitative inputs were triangulated with authoritative technical publications, safety assessments, and standards guidance to ensure factual accuracy and technical depth.

Analytic rigor was applied through thematic coding of interview data, comparative evaluation of formulation and delivery technologies, and assessment of regulatory trajectories across major jurisdictions. Supply chain analysis was informed by documented trade patterns, publicly available tariff schedules, and observed industry responses to policy shifts. Throughout the process, emphasis was placed on defensible interpretation rather than quantitative prognostication, enabling the report to offer prescriptive strategic guidance while avoiding speculative numeric projections. This methodology ensures the findings are grounded in practitioner experience, technical evidence, and observed market behaviors that together inform practical decision-making.

Concluding synthesis that ties technological, regulatory, and supply chain themes together to outline strategic imperatives for sustained competitive advantage

In summary, the antimicrobial ingredients sector is at an inflection point where technological innovation, regulatory evolution, and geopolitical considerations are collectively shaping product development and procurement strategies. Organizations that proactively prioritize safe, sustainable chemistries, diversify supply chains, and align cross-functional teams will be best positioned to respond to shifting end-use requirements. Strategic investments in encapsulation, controlled-release formats, and standardized natural extract production can yield competitive differentiation, while robust regulatory engagement reduces time-to-compliance for critical applications.

Moreover, the current trade and tariff environment underscores the importance of supply chain agility and contract flexibility. By integrating scenario planning, supplier qualification, and localized manufacturing options into strategic roadmaps, companies can reduce vulnerability to policy shocks and maintain continuity for essential product lines. Ultimately, firms that balance innovation with operational discipline and transparent safety validation will capture more durable value and sustain trust with demanding institutional buyers and consumers alike.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising demand for multifunctional antimicrobial peptides in cosmetic formulations to combat skin pathogens
  • 5.2. Integration of silver nanoparticles in advanced wound dressing materials for sustained antimicrobial efficacy
  • 5.3. Utilization of natural plant-derived antimicrobials as alternatives to synthetic preservatives in food packaging
  • 5.4. Development of biofilm-resistant antimicrobial coatings for high-touch medical devices and equipment
  • 5.5. Emerging regulations driving the adoption of non-triazole antifungals in household cleaning products
  • 5.6. Innovations in enzyme-based antimicrobial solutions targeting antibiotic-resistant bacteria in agriculture

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Antimicrobial Ingredients Market, by Application

  • 8.1. Agriculture
    • 8.1.1. Animal Feed Additives
    • 8.1.2. Crop Protection
  • 8.2. Food And Beverage
    • 8.2.1. Food Preservation
    • 8.2.2. Surface Sanitation
  • 8.3. Healthcare
    • 8.3.1. Hospital Disinfectants
    • 8.3.2. Medical Device Coatings
  • 8.4. Household Cleaners
    • 8.4.1. Laundry Additives
    • 8.4.2. Surface Cleaners
  • 8.5. Personal Care
    • 8.5.1. Antimicrobial Soap
    • 8.5.2. Deodorants
    • 8.5.3. Oral Care
  • 8.6. Water Treatment
    • 8.6.1. Drinking Water
    • 8.6.2. Wastewater Treatment

9. Antimicrobial Ingredients Market, by Type

  • 9.1. Natural Extracts
    • 9.1.1. Essential Oils
      • 9.1.1.1. Tea Tree Oil
      • 9.1.1.2. Thyme Oil
    • 9.1.2. Plant Extracts
      • 9.1.2.1. Grapefruit Seed Extract
  • 9.2. Organic Acids
    • 9.2.1. Benzoic Acid
    • 9.2.2. Propionic Acid
    • 9.2.3. Sorbic Acid
  • 9.3. Phenolic Compounds
    • 9.3.1. Orthophenylphenol
    • 9.3.2. Triclosan
  • 9.4. Quaternary Ammonium Compounds
    • 9.4.1. Benzalkonium Chloride
    • 9.4.2. Didecyldimethylammonium Chloride
  • 9.5. Silver Based
    • 9.5.1. Colloidal Silver
    • 9.5.2. Silver Zeolite

10. Antimicrobial Ingredients Market, by Form

  • 10.1. Foam
    • 10.1.1. Aerosol Foam
    • 10.1.2. Non Aerosol Foam
  • 10.2. Gel
    • 10.2.1. Standard Gel
    • 10.2.2. Thixotropic Gel
  • 10.3. Liquid
    • 10.3.1. Aqueous Solution
    • 10.3.2. Emulsion
  • 10.4. Powder
    • 10.4.1. Granules
    • 10.4.2. Microcapsules

11. Antimicrobial Ingredients Market, by Function

  • 11.1. Coating
    • 11.1.1. Industrial Coating
    • 11.1.2. Medical Device Coating
  • 11.2. Disinfectant
    • 11.2.1. Instrument Disinfectant
    • 11.2.2. Surface Disinfectant
  • 11.3. Preservative
    • 11.3.1. Cosmetic Preservative
    • 11.3.2. Food Preservative
  • 11.4. Sanitizer
    • 11.4.1. Hand Sanitizer
    • 11.4.2. Surface Sanitizer

12. Antimicrobial Ingredients Market, by Source

  • 12.1. Natural
    • 12.1.1. Microbial Fermentation
      • 12.1.1.1. Bacteriocins
      • 12.1.1.2. Enzymatic Extracts
    • 12.1.2. Plant Based
  • 12.2. Synthetic
    • 12.2.1. Bio Based Synthetic
    • 12.2.2. Petrochemical Derived

13. Antimicrobial Ingredients Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Antimicrobial Ingredients Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Antimicrobial Ingredients Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Lonza Group AG
    • 16.3.2. BASF SE
    • 16.3.3. Dow Inc.
    • 16.3.4. Evonik Industries AG
    • 16.3.5. Solvay S.A.
    • 16.3.6. DuPont de Nemours, Inc.
    • 16.3.7. LANXESS AG
    • 16.3.8. Clariant AG
    • 16.3.9. Arkema S.A.
    • 16.3.10. Ashland Global Holdings Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FORM, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FUNCTION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FUNCTION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SOURCE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ANTIMICROBIAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ANTIMICROBIAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ANTIMICROBIAL INGREDIENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AGRICULTURE, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AGRICULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AGRICULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AGRICULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AGRICULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AGRICULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ANIMAL FEED ADDITIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ANIMAL FEED ADDITIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ANIMAL FEED ADDITIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ANIMAL FEED ADDITIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ANIMAL FEED ADDITIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ANIMAL FEED ADDITIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY CROP PROTECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY CROP PROTECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY CROP PROTECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY CROP PROTECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY CROP PROTECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY CROP PROTECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD AND BEVERAGE, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD AND BEVERAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD AND BEVERAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD AND BEVERAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD AND BEVERAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD PRESERVATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD PRESERVATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD PRESERVATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD PRESERVATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD PRESERVATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD PRESERVATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SURFACE SANITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SURFACE SANITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SURFACE SANITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SURFACE SANITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SURFACE SANITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SURFACE SANITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HEALTHCARE, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HEALTHCARE, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOSPITAL DISINFECTANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOSPITAL DISINFECTANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOSPITAL DISINFECTANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOSPITAL DISINFECTANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOSPITAL DISINFECTANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOSPITAL DISINFECTANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY MEDICAL DEVICE COATINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY MEDICAL DEVICE COATINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY MEDICAL DEVICE COATINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY MEDICAL DEVICE COATINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY MEDICAL DEVICE COATINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY MEDICAL DEVICE COATINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOUSEHOLD CLEANERS, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOUSEHOLD CLEANERS, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOUSEHOLD CLEANERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOUSEHOLD CLEANERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOUSEHOLD CLEANERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOUSEHOLD CLEANERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOUSEHOLD CLEANERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HOUSEHOLD CLEANERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY LAUNDRY ADDITIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY LAUNDRY ADDITIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY LAUNDRY ADDITIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY LAUNDRY ADDITIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY LAUNDRY ADDITIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY LAUNDRY ADDITIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SURFACE CLEANERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SURFACE CLEANERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SURFACE CLEANERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SURFACE CLEANERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SURFACE CLEANERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SURFACE CLEANERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PERSONAL CARE, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PERSONAL CARE, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PERSONAL CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PERSONAL CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PERSONAL CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PERSONAL CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PERSONAL CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PERSONAL CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ANTIMICROBIAL SOAP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ANTIMICROBIAL SOAP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ANTIMICROBIAL SOAP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ANTIMICROBIAL SOAP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ANTIMICROBIAL SOAP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ANTIMICROBIAL SOAP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DEODORANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DEODORANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DEODORANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DEODORANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DEODORANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DEODORANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORAL CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORAL CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORAL CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORAL CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORAL CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORAL CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WATER TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WATER TREATMENT, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WATER TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WATER TREATMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WATER TREATMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WATER TREATMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WATER TREATMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WATER TREATMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DRINKING WATER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DRINKING WATER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DRINKING WATER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DRINKING WATER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DRINKING WATER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DRINKING WATER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WASTEWATER TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WASTEWATER TREATMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WASTEWATER TREATMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WASTEWATER TREATMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WASTEWATER TREATMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY WASTEWATER TREATMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NATURAL EXTRACTS, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NATURAL EXTRACTS, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NATURAL EXTRACTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NATURAL EXTRACTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NATURAL EXTRACTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NATURAL EXTRACTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NATURAL EXTRACTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NATURAL EXTRACTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ESSENTIAL OILS, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ESSENTIAL OILS, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ESSENTIAL OILS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ESSENTIAL OILS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ESSENTIAL OILS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ESSENTIAL OILS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ESSENTIAL OILS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ESSENTIAL OILS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TEA TREE OIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TEA TREE OIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TEA TREE OIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TEA TREE OIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TEA TREE OIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TEA TREE OIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY THYME OIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY THYME OIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY THYME OIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY THYME OIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY THYME OIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY THYME OIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PLANT EXTRACTS, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PLANT EXTRACTS, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PLANT EXTRACTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PLANT EXTRACTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PLANT EXTRACTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PLANT EXTRACTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PLANT EXTRACTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PLANT EXTRACTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GRAPEFRUIT SEED EXTRACT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GRAPEFRUIT SEED EXTRACT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GRAPEFRUIT SEED EXTRACT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GRAPEFRUIT SEED EXTRACT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GRAPEFRUIT SEED EXTRACT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GRAPEFRUIT SEED EXTRACT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORGANIC ACIDS, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORGANIC ACIDS, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORGANIC ACIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORGANIC ACIDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORGANIC ACIDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORGANIC ACIDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORGANIC ACIDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORGANIC ACIDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BENZOIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BENZOIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BENZOIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BENZOIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BENZOIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BENZOIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PROPIONIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PROPIONIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PROPIONIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PROPIONIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PROPIONIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PROPIONIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SORBIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SORBIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SORBIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SORBIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SORBIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SORBIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PHENOLIC COMPOUNDS, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PHENOLIC COMPOUNDS, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PHENOLIC COMPOUNDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PHENOLIC COMPOUNDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PHENOLIC COMPOUNDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PHENOLIC COMPOUNDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PHENOLIC COMPOUNDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY PHENOLIC COMPOUNDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORTHOPHENYLPHENOL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORTHOPHENYLPHENOL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORTHOPHENYLPHENOL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORTHOPHENYLPHENOL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORTHOPHENYLPHENOL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORTHOPHENYLPHENOL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TRICLOSAN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TRICLOSAN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TRICLOSAN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TRICLOSAN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TRICLOSAN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TRICLOSAN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUNDS, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUNDS, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUNDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUNDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUNDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUNDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUNDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUNDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BENZALKONIUM CHLORIDE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BENZALKONIUM CHLORIDE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BENZALKONIUM CHLORIDE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BENZALKONIUM CHLORIDE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BENZALKONIUM CHLORIDE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BENZALKONIUM CHLORIDE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DIDECYLDIMETHYLAMMONIUM CHLORIDE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DIDECYLDIMETHYLAMMONIUM CHLORIDE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DIDECYLDIMETHYLAMMONIUM CHLORIDE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DIDECYLDIMETHYLAMMONIUM CHLORIDE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DIDECYLDIMETHYLAMMONIUM CHLORIDE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY DIDECYLDIMETHYLAMMONIUM CHLORIDE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER BASED, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER BASED, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COLLOIDAL SILVER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COLLOIDAL SILVER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COLLOIDAL SILVER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COLLOIDAL SILVER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COLLOIDAL SILVER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COLLOIDAL SILVER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER ZEOLITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER ZEOLITE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER ZEOLITE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER ZEOLITE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER ZEOLITE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY SILVER ZEOLITE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOAM, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOAM, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOAM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOAM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOAM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOAM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOAM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOAM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AEROSOL FOAM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AEROSOL FOAM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AEROSOL FOAM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AEROSOL FOAM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AEROSOL FOAM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AEROSOL FOAM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NON AEROSOL FOAM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NON AEROSOL FOAM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NON AEROSOL FOAM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NON AEROSOL FOAM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NON AEROSOL FOAM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY NON AEROSOL FOAM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GEL, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GEL, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY GEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY STANDARD GEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY STANDARD GEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY STANDARD GEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY STANDARD GEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY STANDARD GEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY STANDARD GEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY THIXOTROPI